Nuvalent, Inc.

Nuvalent, Inc.

Biotechnology Research

Cambridge, Massachusetts 5,744 followers

#PreciselyTargetedTherapies for patients with cancer

About us

Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs. To learn more, visit www.nuvalent.com.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Cambridge, Massachusetts
Type
Privately Held
Founded
2017

Locations

  • Primary

    One Broadway 14th Floor

    Cambridge, Massachusetts 02142, US

    Get directions

Employees at Nuvalent, Inc.

Updates

Similar pages

Browse jobs

Funding

Nuvalent, Inc. 5 total rounds

Last Round

Post IPO equity

US$ 575.0M

See more info on crunchbase